Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Luc Van Parys"'
Autor:
Maya Merabishvili, Jean-Paul Pirnay, Gilbert Verbeken, Nina Chanishvili, Marina Tediashvili, Nino Lashkhi, Thea Glonti, Victor Krylov, Jan Mast, Luc Van Parys, Rob Lavigne, Guido Volckaert, Wesley Mattheus, Gunther Verween, Peter De Corte, Thomas Rose, Serge Jennes, Martin Zizi, Daniel De Vos, Mario Vaneechoutte
Publikováno v:
PLoS ONE, Vol 4, Iss 3, p e4944 (2009)
We describe the small-scale, laboratory-based, production and quality control of a cocktail, consisting of exclusively lytic bacteriophages, designed for the treatment of Pseudomonas aeruginosa and Staphylococcus aureus infections in burn wound patie
Externí odkaz:
https://doaj.org/article/46c4fe5e93b84b9fbe09925f1a27cc32
Autor:
Miguel Garcia, Daniel De Vos, Jérôme Gabard, Andrzej Górski, Nina Chanishvili, Olivier Patey, Gilbert Verbeken, Mikael Skurnik, Christine Rohde, Jacques Scheres, Laurent Bretaudeau, Laurent Debarbieux, Angus Buckling, Flavie Pouilot, Mario Vaneechoutte, Jason R. Clark, Volker Côrte-Real Sofia, Kaarle J. Parikka, Martin Zizi, Elizabeth Kutter, Alain Dublanchet, Rob Lavigne, Grégory Resch, Isabelle Huys, John Hardcastle, Bob G. Blasdel, Jean-Paul Pirnay, Luc Van Parys, Guy Van den Eede, Ewa Olchawa, Maia Merabishvili, Marina Goderdzishvili
Publikováno v:
Pharmaceutical Research
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2015, 32 (7), pp.2173-9. ⟨10.1007/s11095-014-1617-7⟩
Pharmaceutical research, 32 (7
Pharmaceutical Research, vol. 32, no. 7, pp. 2173-2179
PHARMACEUTICAL RESEARCH
Pharmaceutical Research, 32(7), 2173-2179. Springer Verlag
Pharmaceutical Research, 2015, 32 (7), pp.2173-9. ⟨10.1007/s11095-014-1617-7⟩
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2015, 32 (7), pp.2173-9. ⟨10.1007/s11095-014-1617-7⟩
Pharmaceutical research, 32 (7
Pharmaceutical Research, vol. 32, no. 7, pp. 2173-2179
PHARMACEUTICAL RESEARCH
Pharmaceutical Research, 32(7), 2173-2179. Springer Verlag
Pharmaceutical Research, 2015, 32 (7), pp.2173-9. ⟨10.1007/s11095-014-1617-7⟩
The worldwide antibiotic crisis has led to a renewed interest in phage therapy. Since time immemorial phages control bacterial populations on Earth. Potent lytic phages against bacterial pathogens can be isolated from the environment or selected from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104c773ece3e9ee2f6616b5639ec1563
https://hal-pasteur.archives-ouvertes.fr/pasteur-01539084
https://hal-pasteur.archives-ouvertes.fr/pasteur-01539084
Autor:
Daniel De Vos, Nina Chanishvili, Marina Tediashvili, Thea Glonti, Guido Volckaert, Wesley Mattheus, Gilbert Verbeken, Mario Vaneechoutte, Peter De Corte, Rob Lavigne, Nino Lashkhi, Thomas Rose, Victor N. Krylov, Luc Van Parys, Jean-Paul Pirnay, Gunther Verween, Jan Mast, Maya Merabishvili, Serge Jennes, Martin Zizi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 4, Iss 3, p e4944 (2009)
PLOS ONE
PLoS ONE, Vol 4, Iss 3, p e4944 (2009)
PLOS ONE
We describe the small-scale, laboratory-based, production and quality control of a cocktail, consisting of exclusively lytic bacteriophages, designed for the treatment of Pseudomonas aeruginosa and Staphylococcus aureus infections in burn wound patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f0320c3ba9234298ea8913cf257b48
http://europepmc.org/articles/PMC2654153
http://europepmc.org/articles/PMC2654153